ESH AL 2018 | Clinical approaches in Ph+ and Ph-like ALL
Robin Foà
Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Robin Foà, MD, from the University of Rome, Rome, Italy, talks about the clinical approach when treating patients with Ph+ or Ph-like acute lymphoblastic leukemia (ALL).
Related videos
Anti-CD19 CAR T-cell therapy in combination with ibrutinib for CLL/SLL
Saar Gill
An exciting era for CAR T-cell therapy
Mohamad Mohty
Ibrutinib combinations for CLL: iLLUMINATE results & more
Carol Moreno
JCAR017 for relapsed/refractory CLL
Tanya Siddiqi
Combining novel agents for CLL to achieve deep remissions: time-limited therapy, treatment cessation & drug re-use in relapse
Talha Munir
